HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Li Selected Research

Single-Chain Antibodies

1/2022Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia.
7/2014The preparation of VEGFR1/CD3 bispecific antibody and its specific cytotoxicity against VEGFR1-positive breast cancer cells.
4/2012[Construction, expression and characterization of the fusion gene of super-antigen SEA and single chain Fv of the ND-1 monoclonal antibody against human colorectal cancer].
10/2002Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistry.
9/2002[Screening and application of human-derived HBsAg bacteriophage single chain antibody in clinical diagnosis].
4/2002[Preparation of human single chain Fv antibody specifically against hepatitis C virus E2 antigen].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Li Research Topics

Disease

1436Neoplasms (Cancer)
06/2024 - 01/2002
363Inflammation (Inflammations)
05/2024 - 01/2002
313Infections
05/2024 - 01/2002
240Breast Neoplasms (Breast Cancer)
04/2024 - 03/2002
229Neoplasm Metastasis (Metastasis)
12/2024 - 03/2002
157Carcinogenesis
04/2024 - 05/2002
137Ovarian Neoplasms (Ovarian Cancer)
03/2024 - 11/2002
128Hepatocellular Carcinoma (Hepatoma)
04/2024 - 02/2003
125Colorectal Neoplasms (Colorectal Cancer)
12/2024 - 07/2003
120Pain (Aches)
04/2024 - 04/2002
117Fibrosis (Cirrhosis)
02/2024 - 05/2004
111Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 11/2003
102Hypertension (High Blood Pressure)
04/2024 - 01/2005
100Carcinoma (Carcinomatosis)
03/2024 - 03/2002
99COVID-19
03/2024 - 01/2020
97Hypoxia (Hypoxemia)
03/2024 - 05/2003
84Wounds and Injuries (Trauma)
03/2024 - 01/2005
83Lung Neoplasms (Lung Cancer)
05/2024 - 04/2005
83Obesity
05/2024 - 05/2005
83Body Weight (Weight, Body)
02/2024 - 01/2006
78Stomach Neoplasms (Stomach Cancer)
04/2024 - 03/2002
76Type 2 Diabetes Mellitus (MODY)
04/2024 - 05/2002
73Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2024 - 03/2004
71Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 02/2006
69Insulin Resistance
05/2024 - 05/2002
67Nasopharyngeal Carcinoma
10/2023 - 04/2006
63Atherosclerosis
06/2024 - 02/2002
61Necrosis
02/2024 - 03/2002
59Myocardial Infarction
01/2024 - 04/2002
58Hemorrhage
06/2024 - 04/2002
58Sepsis (Septicemia)
05/2024 - 08/2010
58Stroke (Strokes)
05/2024 - 12/2002
53Ischemia
02/2024 - 11/2003
53Colonic Neoplasms (Colon Cancer)
06/2023 - 02/2008
51Glioma (Gliomas)
01/2024 - 05/2002
50Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 07/2003
49Reperfusion Injury
05/2024 - 04/2002
48Alzheimer Disease (Alzheimer's Disease)
07/2024 - 01/2005
48Asthma (Bronchial Asthma)
05/2024 - 01/2002
48Liver Neoplasms (Liver Cancer)
04/2024 - 07/2002
48Disease Progression
02/2024 - 01/2006
46Thrombosis (Thrombus)
02/2024 - 01/2011
46Prostatic Neoplasms (Prostate Cancer)
01/2024 - 10/2003
45Leukemia
02/2024 - 07/2003
40Heart Failure
05/2024 - 01/2003
40Mitochondrial Diseases (Mitochondrial Disease)
05/2024 - 06/2003
39Chronic Obstructive Pulmonary Disease (COPD)
05/2024 - 01/2002
39Ischemic Stroke
05/2024 - 09/2014
39Adenocarcinoma of Lung
01/2024 - 05/2003
39Hepatitis B
01/2024 - 09/2002

Drug/Important Bio-Agent (IBA)

648Proteins (Proteins, Gene)FDA Link
05/2024 - 02/2002
312Biomarkers (Surrogate Marker)IBA
07/2024 - 05/2004
188Messenger RNA (mRNA)IBA
04/2024 - 04/2002
175CytokinesIBA
03/2024 - 09/2003
163MicroRNAs (MicroRNA)IBA
12/2024 - 01/2010
114Glucose (Dextrose)FDA LinkGeneric
05/2024 - 05/2002
110Long Noncoding RNAIBA
04/2024 - 01/2016
104DNA (Deoxyribonucleic Acid)IBA
05/2024 - 10/2002
103EnzymesIBA
12/2023 - 02/2003
98RNA (Ribonucleic Acid)IBA
05/2024 - 09/2003
96VaccinesIBA
05/2024 - 08/2003
90LipidsIBA
04/2024 - 05/2002
84Therapeutic UsesIBA
05/2024 - 12/2002
78AntigensIBA
12/2023 - 05/2003
74Peptides (Polypeptides)IBA
03/2024 - 01/2005
73Small Interfering RNA (siRNA)IBA
02/2024 - 09/2006
69Cisplatin (Platino)FDA LinkGeneric
03/2024 - 11/2002
68Interleukin-6 (Interleukin 6)IBA
05/2024 - 01/2005
65Phosphotransferases (Kinase)IBA
05/2024 - 05/2002
62Transcription Factors (Transcription Factor)IBA
03/2024 - 04/2005
61Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024 - 06/2003
57AntioxidantsIBA
05/2024 - 08/2003
56Anti-Bacterial Agents (Antibiotics)IBA
03/2024 - 08/2010
55CateninsIBA
04/2024 - 10/2011
55LigandsIBA
01/2024 - 01/2004
54CollagenIBA
02/2024 - 11/2004
54Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2023 - 01/2002
50Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2024 - 01/2002
49Insulin (Novolin)FDA Link
05/2024 - 05/2002
47Indicators and Reagents (Reagents)IBA
01/2024 - 04/2002
45Antiviral Agents (Antivirals)IBA
05/2024 - 09/2006
44Hormones (Hormone)IBA
04/2024 - 09/2006
42CalciumIBA
01/2024 - 10/2005
41LipopolysaccharidesIBA
03/2024 - 07/2002
41AntibodiesIBA
06/2023 - 04/2003
40Oxygen (Dioxygen)IBA
03/2024 - 04/2002
40Doxorubicin (Adriamycin)FDA LinkGeneric
01/2024 - 07/2004
40CholesterolIBA
01/2024 - 05/2002
39Tyrosine Kinase InhibitorsIBA
05/2024 - 12/2010
39AcidsIBA
03/2024 - 01/2003
37ErbB Receptors (EGF Receptor)IBA
05/2024 - 10/2004
37Monoclonal AntibodiesIBA
04/2024 - 01/2002

Therapy/Procedure

695Therapeutics
06/2024 - 01/2002
203Drug Therapy (Chemotherapy)
04/2024 - 11/2002
110Immunotherapy
04/2024 - 07/2003
96Radiotherapy
04/2024 - 11/2003
50Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 02/2007
46Transplantation
03/2024 - 06/2003
40Aftercare (After-Treatment)
05/2024 - 02/2002
39Stents
02/2024 - 11/2005